发明申请
US20050124610A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
有权
用于治疗激酶障碍的氨基取代的吡啶酮甲酮化合物
- 专利标题： Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
- 专利标题（中）： 用于治疗激酶障碍的氨基取代的吡啶酮甲酮化合物
-
申请号： US10981087申请日： 2004-11-04
-
公开(公告)号： US20050124610A1公开(公告)日： 2005-06-09
- 发明人: Ronghui Lin , Steven Wetter , Yanhua Lu , Peter Connolly , Stuart Emanuel , Robert Gruninger , Steven Middleton
- 申请人： Ronghui Lin , Steven Wetter , Yanhua Lu , Peter Connolly , Stuart Emanuel , Robert Gruninger , Steven Middleton
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; A61K31/443 ; A61K31/4436 ; A61K31/4439 ; A61K31/444 ; C07D213/72 ; C07D213/73 ; C07D213/74 ; C07D213/75 ; C07D401/02 ; C07D405/02 ; C07D405/06 ; C07D409/02 ; C07D409/06 ; C07D413/02 ; C07D417/02 ; C07D43/02
摘要：
The present invention provides amino substituted pyridinyl methanone compounds; pharmaceutical compositions comprising the compounds and methods of synthesis thereof. The compounds, which are cyclin dependent kinase (CDK) inhibitors, can be used to treat or ameliorate CDK mediated disorders. The invention thus also provides the therapeutic or prophylactic use of the compounds and/or pharmaceutical compositions to treat such disorders.
公开/授权文献
信息查询
